Max Masucci analyst

Currently out of the existing stock ratings of Max Masucci, 11 are a HOLD (13.1%), 73 are a BUY (86.9%).

Max Masucci

Work Performance Price Targets & Ratings Chart

Analyst Max Masucci, carries an average stock price target met ratio of 48.68% that have a potential upside of 21.18% achieved within 164 days. Previously, Max Masucci worked at TD COWEN, CANACCORD.

Max Masucci’s has documented 157 price targets and ratings displayed on 24 stocks. The coverage was on Healthcare, Energy sectors.

Most recent stock forecast was given on CTKB, Cytek Biosciences at 08-Nov-2023.

Wall Street Analyst Max Masucci

Analyst best performing recommendations are on QTRX (QUANTERIX CORP).
The best stock recommendation documented was for QTRX (QUANTERIX CORP) at 10/6/2020. The price target of $40 was fulfilled within 1 day with a profit of $3.1 (8.4%) receiving and performance score of 84.01.

Average potential price target upside

BDSX Biodesix  GNMK GenMark Diagnostics ILMN Illumina NTRA Natera BLFS BioLife Solutions DMTK DermTech QTRX Quanterix Corp ISO IsoPlexis Corp MXCT MaxCyte NAUT Nautilus Biotechnology SMFR Sema4 Holdings Corp TKNO Alpha Teknova XGN Exagen GH Guardant Health HOLX Hologic PKI PerkinElmer EVO Evotec SE ADR BRKR Bruker CDXS Codexis CTKB Cytek Biosciences GTH Genetron Holdings Ltd CEMI Chembio Diagnostics SM SM Energy Co CSTL Castle Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2021

$35

$8.03 (29.77%)

$27

1 months 3 days ago
(10-Aug-2026)

8/9 (88.89%)

$10.14 (40.79%)

321

Hold Since 18-Nov-2021

$4400

4 years 4 months 1 days ago
(12-May-2022)

1/3 (33.33%)

$4270.8 (3305.57%)

38

Buy Since 02-Feb-2021

$620

4 years 4 months 24 days ago
(20-Apr-2022)

0/2 (0%)

$145.4 (30.64%)

$17

$3.87 (29.47%)

4 years 9 months 20 days ago
(24-Nov-2021)

2/2 (100%)

$-117.6 (-87.37%)

790

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?